US20090198329A1 - Breast implant with internal flow dampening - Google Patents

Breast implant with internal flow dampening Download PDF

Info

Publication number
US20090198329A1
US20090198329A1 US12024835 US2483508A US2009198329A1 US 20090198329 A1 US20090198329 A1 US 20090198329A1 US 12024835 US12024835 US 12024835 US 2483508 A US2483508 A US 2483508A US 2009198329 A1 US2009198329 A1 US 2009198329A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
membrane
cell structure
open cell
implantable prosthesis
prosthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12024835
Inventor
Randy J. Kesten
Michael D. Lesh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evera Medical Inc
Original Assignee
Evera Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/12Mammary prostheses and implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0059Cosmetic or alloplastic implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0077Special surfaces of prostheses, e.g. for improving ingrowth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/50Prostheses not implantable in the body
    • A61F2/52Mammary prostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0034D-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0093Umbrella-shaped, e.g. mushroom-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0003Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having an inflatable pocket filled with fluid, e.g. liquid or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0004Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
    • A61F2250/0009Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable for adjusting thickness
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0004Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
    • A61F2250/001Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable for adjusting a diameter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0004Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
    • A61F2250/0012Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable for adjusting elasticity, flexibility, spring rate or mechanical tension
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0004Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
    • A61F2250/0013Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable for adjusting fluid pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0015Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in density or specific weight
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0023Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in porosity
    • A61F2250/0024Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in porosity made from both porous and non-porous parts, e.g. adjacent parts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0025Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in roughness
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0028Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in fibre orientations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0051Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in tissue ingrowth capacity, e.g. made from both ingrowth-promoting and ingrowth-preventing parts

Abstract

An implantable prosthesis is provided having a membrane which holds a flowable substance. The membrane is separated into a first chamber and a second chamber with the first and second chambers being fluidly coupled via an orifice. The orifice has a size which may be adjusted by the user after implanting the prosthesis into the patient.

Description

    BACKGROUND OF THE INVENTION
  • The present invention is directed to an implantable prosthesis which may be used anywhere in the body such as the breast.
  • An implant provides support for the surrounding body tissue and occupies voids created by the removal of tissue to preserve the normal outward appearance and feel of the body. Prosthetic devices have also been used to enhance or augment the appearance of body parts.
  • Breast prostheses have long been used for breast augmentation and for reconstruction such as following a mastectomy. The prostheses are available in numerous sizes and shapes including teardrop, round and low profile. Usually, breast prostheses are implanted via a small intramammary or pari-aerolar incision into a pocket dissected deep into the patient's own breast tissue in front of the pectoral muscle. In certain situations, the prosthesis may be placed behind the various chest muscles.
  • Some prosthetic devices have utilized an outer shell or envelope which is filled with a flowable substance such as silicone gel or saline. These prior art devices have tactile properties similar to normal tissue but suffer from certain disadvantages. Saline filled prosthetic devices can lack the proper appearance and tactile properties of normal tissue. Saline displaces relatively quickly and can create a fluid wave in the implant which presents an unnatural look and an audible sound. Saline filled implants also lack form stability which may result in the implant folding over itself or visible wrinkling.
  • The object of the present invention is to overcome some of the drawbacks of the prior art implants. The object of the present invention is to construct a surgically implantable prosthetic device which may be filled with saline and/or other fluids and which has desirable tactile appearance and other characteristics.
  • SUMMARY OF THE INVENTION
  • The implantable prosthesis of the present invention includes a membrane and an open cell structure contained within the membrane. The open cell structure dampens fluid motion within the membrane to reduce some of the problems with prior art devices as described above.
  • In one aspect of the invention, the implantable prosthesis has an orifice of adjustable size. The orifice provides fluid communication between a first chamber and a second chamber in the membrane. The size of the orifice may be adjusted after implantation of the prosthesis using a control element.
  • In another aspect of the present invention, an implantable prosthesis is provided which has a tension element extending between two locations on the membrane. The tension on the tension element may be altered before or after introduction of the prosthesis into the patient. The tension element may extend through a seal which permits tensioning of the tension element while preventing the flowable substance from leaking out of the membrane.
  • In a further aspect of the present invention, the open-cell structure may have a plurality of voids which are substantially larger than the cells of the open-cell structure. The voids may be symmetrically positioned relative to an axis of symmetry in the membrane.
  • In still another aspect of the present invention, the open cell structure may have a natural, unbiased shape which is larger than the membrane. The open cell structure is compressed and positioned within the membrane so that the membrane holds the open cell structure in a collapsed shape.
  • The open cell structure may also include a channel extending along an outer surface of the open cell structure and adjacent to the inner surface of the membrane. The channel enhances fluid flow in this region and, in particular, in the area between the membrane and the open cell structure. The channels may be oriented radially with respect to an apex of the membrane, circumferentially or in any other suitable manner.
  • A plurality of spacers may also be used between the open cell structure and the membrane. The spacers provide an area between the membrane and the open cell structure which enhances fluid flow in the area between the membrane and open cell structure. The spacers may be attached to the external surface of the open cell structure or to the inner surface of the membrane.
  • The open cell structure may be selectively attached to the membrane at discrete locations which are separated by areas where the open cell structure is free to slide against the inner surface of the membrane. The attachments may be along the anterior wall and/or posterior wall so that portions of the anterior and/or posterior wall are free of attachments to the open cell structure. The attachments may be along a continuous strip of the membrane which, for example, forms a loops that encircles the apex of the membrane.
  • These and other features of the present invention will become apparent from the following description of the preferred embodiments.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 shows an implantable prosthesis.
  • FIG. 2 is a top view of the implantable prosthesis of FIG. 1.
  • FIG. 3 shows an internal wall having an orifice.
  • FIG. 4 shows the internal wall in an expanded shape which reduces the size of the orifice.
  • FIG. 5 shows the internal wall separated from the rest of the prosthesis.
  • FIG. 6 shows the internal wall expanded to collapse the orifice.
  • FIG. 7 shows another implantable prosthesis having tension elements which may be selectively tensioned by the user.
  • FIG. 8 shows a plan view of the prosthesis of FIG. 7.
  • FIG. 9 shows another implantable prosthesis having tension members.
  • FIG. 10 shows a plan view of the prosthesis of FIG. 9.
  • FIG. 11 shows another implantable prosthesis having a chamber which may be filled or evacuated.
  • FIG. 12 shows the chamber of FIG. 11 expanded.
  • FIG. 13 is a plan view of the implantable prosthesis of FIG. 12.
  • FIG. 14 shows another implantable prosthesis.
  • FIG. 15 is a plan view of the implantable prosthesis of FIG. 14.
  • FIG. 16 shows an open cell structure.
  • FIG. 17 shows a membrane which is smaller than the open cell structure of FIG. 16.
  • FIG. 18 shows another implantable prosthesis.
  • FIG. 19 is a plan view of the implantable prosthesis of FIG. 18.
  • FIG. 20 shows still another implantable prosthesis having radially oriented channels.
  • FIG. 21 is a plan view of the implantable prosthesis of FIG. 20.
  • FIG. 22 shows another implantable prosthesis having circumferential channels.
  • FIG. 23 is a plan view of the implantable prosthesis of FIG. 22.
  • FIG. 24 shows still another implantable prosthesis with a circumferential channel.
  • FIG. 25 is a plan view of the implantable prosthesis of FIG. 24.
  • FIG. 26 shows another implantable prosthesis with a selective number of discrete attachments along the posterior and anterior walls.
  • FIG. 27 is a plan view of the prosthesis of FIG. 26.
  • FIG. 28 shows an implantable prosthesis which is attached to the membrane along two circular strips.
  • FIG. 29 is a plan view of the prosthesis of FIG. 28.
  • FIG. 30 shows a plurality of spacers positioned between the membrane and the open cell structure.
  • FIG. 31 shows another embodiment having a plurality of spacers.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • Referring to FIGS. 1-6, an implantable prosthesis 2 is shown. The prosthesis 2 includes a membrane 4 which may be made formed in any suitable manner. The membrane 4 contains a flowable substance 6 such as silicone gel, saline or any other suitable substance. The flowable substance 6 may also include elements (not shown), such as beads or spheres, which are suspended in the flowable substance 6 without departing from the scope of the invention. Any of the embodiments disclosed herein may incorporate features, structures and materials disclosed in U.S. patent application Ser. No. 11/316,215 to Michael Lesh, entitled Tissue Augmentation Device filed Dec. 22, 2005, the disclosure of which is incorporated in its entirety herein by reference.
  • The membrane 4 is divided into a number of chambers 10 separated by walls 12. The walls 12 each have one or more orifices 14 which have a size which may be adjusted. Changing the size of the orifices 14 in the walls 12 alters the flow characteristics of the prosthesis 2 in that a smaller orifice 14 will provide a slower flow rate of the flowable substance 6 between the chambers 10. The chambers 10 may also be filled with a substance which further reduces the flow rate of fluid such as an open-cell structure which may be a matrix of material, a sponge, a foam or any other suitable open-cell structure which reduces the flow rate of fluid within the membrane 4 as described below in connection with other preferred embodiments.
  • The walls 12 include an inflatable element 18 which is inflated or deflated to change the size of the orifice 14. The inflatable element 18 may be formed by bonding two sheets of material 22 together to form the wall 12. The sheets 22 are bonded together around the orifices 14 and a hole is cut to form the orifice 14. Inflation of the space between the sheets 22 causes the inflatable element to expand thereby reducing the size of the orifice 14. A control element 24 is releasably coupled to the membrane 4 and is configured to extend out of the patient after the membrane 4 has been implanted into the patient. The control element 24 permits the user to change the size of the orifice 14 after introducing the prosthesis 2 into the patient. The control element 24 has a lumen coupled to a source of fluid (not shown) and may be provided with a releasable connection to the membrane 4 in any suitable manner. Although the control element 24 is configured to hydraulically alter the size of the orifice 14, the control element 24 may accomplish the change in orifice 14 size using any other method such as mechanical or electrical. For example, the size of the orifice 14 could be modified using a suture which cinches the orifice 14 to reduce the size of the orifice 14.
  • Referring to FIGS. 7 and 8, another implantable prosthesis 30 is shown. The prosthesis 30 includes a membrane 32 which holds the flowable substance 6. The membrane 32 may be filled with an open-cell structure 34 as described above. The prosthesis 30 also includes one or more tension elements 36 which extend between two portions of the wall of the membrane 32 to help maintain a more stable shape. The tension elements 36 may extend through a valve 38 in the prosthesis 30 which permits the tension element 36 to slide therethrough while still maintaining a fluid tight seal. The tension element 36 is coupled to a control element 40 which may simply be a portion of the tension element 36 which extends out of the prosthesis 30. The tension elements 36 may extend from a posterior wall 42 to an anterior wall 44 of the membrane 32 but may, of course, be coupled to other parts of the membrane 32 as well.
  • The control element 40 is configured to extend out of the patient when the prosthesis 30 is implanted so that the user may adjust tension on the tension element 36 after implantation. Tension may be applied to one or more of the tension elements 36 to create a desirable texture and feel to the prosthesis 30. After the desired tension has been applied, the control element 40 may be removed by simply cutting the control element 40 or releasing the control element 40 using any other suitable method. A locking element 43 is coupled to the membrane 32 which automatically secures the tension element 36 after tension has been increased with the control element 40. The control element 40 may, of course, be manipulated prior to implantation of the prosthesis 30.
  • Referring to FIGS. 9 and 10, still another implantable prosthesis 50 is shown. The prosthesis 50 includes a membrane 52 which holds the flowable substance 6. The membrane 52 may also contain an open-cell structure 56 which dampens fluid motion although the invention may be practiced without the open-cell structure 56. A plurality of tension members 58 extend through the open-cell structure 56 and are attached to the membrane 52 at both ends. The membrane 52 may have a round posterior wall 60 which is symmetrical about an axis of symmetry 62. The tension members 58 may extend from one side of the membrane 52 to a diametrically opposed side of the membrane 52. The tension members 58 may also be symmetrically arranged relative to the axis of symmetry 62 and may be coupled together at a junction 64 so that tension is distributed among the tension members 58.
  • Referring to FIGS. 11-13, yet another implantable prosthesis 70 is shown. The prosthesis 70 includes a membrane 72 having a first chamber 74, a second chamber 76 and a third chamber 78. The chambers 74, 76, 78 may be filled with an open-cell structure 80. The second chamber 76 is fluidly isolated from the first and third chambers 74, 78 and may be filled using a removable fill line 82. The second chamber 76 may be filled or evacuated as desired before or after the prosthesis 70 has been implanted into a patient. The second chamber 76 is positioned between the first and third chambers 74, 78 and may generally lie in a plane but may be oriented in any other suitable manner. The first and third chambers 74. 78 may be fluidly isolated from one another or may be fluidly coupled together.
  • Referring to FIGS. 14 and 15, another implantable prosthesis 84 is shown. The prosthesis includes a membrane 86 filled with the flowable substance 6. The prosthesis 84 also includes an open-cell structure 90 which dampens fluid motion and helps to maintain a desired shape. The open-cell structure 90 includes a plurality of voids 92 which are substantially larger than an average cell size in the open-cell structure 90. The membrane 86 may be symmetrical about an axis of symmetry 91 which is centrally located relative to a round posterior wall 94. The round posterior wall 94 and symmetrical shape permit the user to implant the device without requiring a particular orientation when implanted. The voids 92 are preferably symmetrically positioned relative to the axis of symmetry 91. The voids 92 may be elongate channels 96 cut into the open-cell structure 90 which extend from the posterior wall 94 to an anterior wall 95 of the prosthesis 84.
  • Referring again to FIGS. 1 and 9, a cover 96 may be used to cover a portion of an outer surface 99 of the membrane 4 and may be used with any of the implants described herein. The cover 96 may be a strip 98 of expanded PTFE which extends over, and essentially parallel to, an area commonly referred to as the waist 100. The waist 100 is generally defined as a radially outer portion of the membrane 52 when the membrane 52 is supported by the posterior wall 60 as shown in FIG. 9. The cover 96 is positioned so that at least 80% of the ePTFE is positioned no more than 1 cm from the waist 100. Positioning the ePTFE cover 96 in this manner provides the advantages of ePTFE, such as the promotion of in-growth, without the high cost of covering the entire implant with ePTFE as has been suggested by some prior art devices. Of course, numerous aspects of the present invention may be practiced without the cover 96 or with the cover 96 extending around the entire outer surface or a substantial portion thereof without departing from those aspects of the invention.
  • The cover 96 may be applied to the membrane 52 in the following manner when using the strip 98 of ePTFE. The membrane 52 is held at two spaced-apart locations 103, 105 along the waist 100 and the membrane 52 is stretched to increase the space between these locations. The membrane 52 may be held by a curved work element which supports the curved shape of the membrane when the membrane 52 is stretched. The strip 98 is then attached to the membrane at both locations 103, 105 and the membrane 52 is then released to release tension on the membrane 52. This process may be repeated until the entire waist 100 is covered by the strip 98. In one embodiment, the strip 98 is attached at 6-10 locations around the periphery of the waist 100.
  • Referring now to FIGS. 16 and 17, still another aspect of the present invention is shown. An open cell structure 102 is provided which has a natural, unbiased shape which is larger than membrane 104. The open cell structure 102 is compressed within the membrane 104 which holds the open cell structure 102 in a compressed state. The open cell structure 102 may occupy a volume when in the natural unbiased shape which is 5% to 20% larger than the volume of the membrane 104.
  • The open cell structure 102 may be larger than the membrane 104 in all dimensions or may be selectively larger in one or more dimensions. For example, the open cell structure 100 may have a height H which is 5% to 20% larger than a maximum dimension between an anterior wall 106 and a posterior wall 108. The open cell structure 102 may also have a width W which is 5% to 20% larger than a maximum outer dimension or diameter of the posterior wall 108.
  • Referring now to FIGS. 18-25, an implantable prosthesis 109 is shown which has a membrane 110 and an open cell structure 114 with channels 122 formed in an outer surface 124 of the open cell structure 114. The membrane 110 includes a posterior wall 116 and an anterior wall 118 having an apex 120. The channels 122 may be positioned adjacent to an inner surface 126 of the membrane 110 so that the flowable substance can flow in a more unrestricted manner in the channels 122 than in the open cell structure 114. The channels 122 may extend radially relative to the apex 120 of the membrane 112 (FIGS. 18-21). The channels 120 may intersect one another at the inner surface 126 of the membrane 112 below the apex 120 (FIGS. 20 and 21) or may be non-intersecting (FIGS. 18 and 19). Referring to FIGS. 22 and 23, the channel 122 may also extend circumferentially about the outer surface 124 of the open cell structure 114. The channel 122 may also be positioned adjacent to a waist 128 of the membrane which is a radially outer portion of the membrane 110 near the posterior wall 116 as described above. The channel 122 may also extend around the apex 120 of the membrane 110 at a position nearer to the apex 120 than to the waist 128 as shown in FIGS. 24 and 25.
  • Referring now to FIGS. 26-29, open cell structure 130 may be attached to membrane 132 at a selective number of locations which are separated by portions of the open cell structure 130 which are free to move relative to an inner surface 134 of the membrane 132. FIGS. 26 and 27 shows the open cell structure 130 attached to the membrane 132 at four spaced apart locations on anterior wall 136 and posterior wall 138. FIGS. 28 and 29 show the open cell structure 130 attached to the membrane 132 along a strip 140 on the anterior wall 136 and along a strip 142 on the posterior wall 138. The strip 136 on the anterior wall 136 may form a closed loop that encircles the apex of the membrane.
  • Referring now to FIGS. 30 and 31, spacers 144 may also be provided between open cell structure 146 and the membrane 148. The spacers 144 create an area between the membrane 148 and the open cell structure 146 so that the flowable substance may flow in a less restricted manner in this area as compared to within the open cell structure 146. The spacers 144 may be attached to the membrane 148 or to the open cell structure 146 and may be integrally formed with either part. When attached to the open cell structure 146, the spacers 144 are free to slide against an inner surface 150 of the membrane 148. The spacers 144 may be sized and positioned so that less than 20% of an outer surface 152 of the open cell structure 146 is covered by the spacers 144. Stated another way, at least 80% of the outer surface 152 of the open cell structure 146 is free to move relative to the inner surface 150 of the membrane 148. The spacers 144 may be arranged in a radially oriented fashion (FIG. 30) or in a circumferential pattern (FIG. 31) or any other suitable configuration without departing from the scope of the invention.
  • The present invention has been described in connection with various preferred embodiments and it is understood that modifications and alterations of these embodiments may be accomplished while remaining within the scope of the invention as defined by the claims. For example, the implants may be anatomical implants rather than symmetrical implants without departing from the scope of various aspects of the invention. Furthermore, the various aspects of the invention have been described independently but may, of course, be practiced together and such combinations are expressly incorporated. For example, the spacers 144 of FIGS. 30 and 31 could be used in combination with the tension elements 36 of FIGS. of 7 and 8.

Claims (33)

  1. 1. An implantable prosthesis, comprising:
    a soft, flexible outer membrane;
    a flowable substance contained within the membrane;
    an open cell structure positioned inside the membrane, the open cell structure being filled with the flowable substance so that the open cell structure dampens motion of the flowable substance within the membrane.
  2. 2. The implantable prosthesis of claim 1, wherein the membrane includes a first chamber and a second chamber and a flow restricting orifice which fluidly couples the first chamber to the second chamber.
  3. 3. The implantable prosthesis of claim 2, wherein an adjustable flow restricting orifice which fluidly couples the first chamber to the second chamber, the adjustable flow restricting orifice having a control element which permits the user to change a size of the orifice thereby altering a flow resistance between the first and second chambers.
  4. 4. The implantable prosthesis of claim 2, wherein the control element is configured to extend out of the patient when the membrane has been implanted into a patient so that the size of the orifice may be altered after the membrane has been implanted into the patient.
  5. 5. The implantable prosthesis, of claim 1, further comprising: a tension element coupled to the membrane at a first location and a second location; and a control element coupled to the tension element, the control element being configured to increase tension on the tension element so that the tension element draws the first and second locations toward one another.
  6. 6. The prosthesis of claim 5, wherein the control element is configured to extend out of the patient when the membrane has been implanted into a patient so that tension on the tension element may be altered after the membrane has been implanted into the patient.
  7. 7. The prosthesis of claim 5, wherein the membrane has a posterior wall and an anterior wall; and the first location being on the posterior wall and the second location being on the anterior wall.
  8. 8. The prosthesis of claim 5, further comprising a plurality of tension elements extending within the membrane, each of the tension elements being configured to be tensioned independently by the user after introduction of the membrane into the patient.
  9. 9. The implantable prosthesis of claim 1, further comprising a plurality of elastic tension elements extending through the open-cell structure coupled to the membrane, each tension element having a first end and a second end which are both attached to the membrane.
  10. 10. The implantable prosthesis of claim 9, wherein the membrane has a round posterior wall; and the plurality of tension elements extend from one side of the membrane to a diametrically opposed side relative to the circular posterior wall.
  11. 11. The implantable prosthesis of claim 10, wherein the plurality of tension elements are coupled together at a junction which is between the first and second ends of the tension elements.
  12. 12. The implantable prosthesis of claim 1, further comprising a plurality of voids in the open-cell structure which are substantially larger than the cells of the open-cell structure.
  13. 13. The prosthesis of claim 12, wherein the plurality of voids are organized in a symmetrical pattern relative to the axis of symmetry.
  14. 14. The prosthesis of claim 12, wherein the plurality of voids are elongate channels which extend through the open-cell structure.
  15. 15. The implantable prosthesis of claim 1, further comprising a cover material;
    the membrane having an outer surface, a posterior wall, an anterior wall and a waist, the waist being an outer ring which is positioned between the anterior wall and the posterior wall when the membrane is supported by the posterior wall;
    the cover material extending over the membrane and being made of expanded PTFE, wherein at least 80 percent of the expanded ePTFE which covers the membrane is positioned no more than one centimeter from the waist of the membrane.
  16. 16. The prosthesis of claim 15, wherein the outer surface of the membrane is exposed to tissue when implanted into the patient except for the portion of the outer surface covered by the cover material.
  17. 17. The prosthesis claim 15, wherein the cover material is a strip of expanded PTFE which wraps around the membrane in a direction which is parallel to the waist so that the strip covers the outer surface of the membrane along the waist.
  18. 18. The implantable prosthesis of claim 1, wherein the open cell structure has a natural, unbiased shape which is larger than the membrane, the membrane holding the open cell structure in a compressed state which is smaller than the natural unbiased shape.
  19. 19. The implantable prosthesis of claim 1, wherein the membrane includes an inner surface which is exposed to the flowable substance; and the open cell structure includes a channel extending along an outer surface of the open cell structure adjacent to the inner surface of the membrane.
  20. 20. The implantable prosthesis of claim 19, wherein the membrane includes a posterior wall and an anterior wall, the anterior wall having an apex; and the open cell structure includes a plurality of channels which intersect at along the inner surface of the membrane below the apex.
  21. 21. The implantable prosthesis of claim 20, wherein the membrane includes a posterior wall and an anterior wall, the anterior wall having an apex; and the open cell structure includes a plurality of channels which extend radially relative to the apex of the membrane.
  22. 22. The implantable prosthesis of claim 20, wherein the plurality of channels in the open cell structure do not intersect one another.
  23. 23. The implantable prosthesis of claim 19, wherein the channel in the open cell structure extends circumferentially about an external surface of the open cell structure.
  24. 24. The implantable prosthesis of claim 1 wherein the membrane has a posterior wall, an anterior wall and an inner surface which is exposed to the flowable substance; and the open cell structure being selectively attached to the membrane at discrete locations.
  25. 25. The implantable prosthesis of claim 24, wherein the open cell structure is selectively attached at a plurality of locations separated by portions of the open cell structure which are free to move relative to the inner surface of the membrane.
  26. 26. The implantable prosthesis of claim 24, wherein the open cell structure is attached to the posterior wall of the membrane at a plurality of locations separated by portions of the open cell structure which are free to move relative to the inner surface of the membrane along the posterior wall.
  27. 27. The implantable prosthesis of claim 24, wherein the open cell structure is attached to the anterior wall of the membrane at a plurality of locations separated by portions of the open cell structure which are free to move relative to the inner surface of the membrane along the anterior wall.
  28. 28. The implantable prosthesis of claim 25, wherein the open cell structure is selectively attached to the membrane along a strip of the inner surface of the membrane.
  29. 29. The implantable prosthesis of claim 1, further comprising a plurality of spacing elements positioned between the membrane and the open cell structure, the spacing elements forming a space between the membrane and the open cell structure to promote flow of the flowable substance in the space between the membrane and the open cell structure.
  30. 30. The implantable prosthesis of claim 29, wherein the membrane has an inner surface which is the open cell structure has an outer surface; and the plurality of spacing elements cover less than 20% of the outer surface of the open cell structure so that at least 80% of the outer surface is exposed and free to move relative to an inner surface of the membrane.
  31. 31. The implantable prosthesis of claim 18, wherein the open cell structure has a volume in its natural unbiased shape that is 5% to 20% larger than the volume of the membrane.
  32. 32. The implantable prosthesis of claim 18, wherein the open cell structure has a height in its natural unbiased shape that is 5% to 20% larger than the maximum length between an anterior wall and a posterior wall of the membrane.
  33. 33. The implantable prosthesis of claim 18, wherein the open cell structure has a width in its natural unbiased shape that is 5% to 20% larger than the maximum width or diameter of a posterior wall of the membrane.
US12024835 2008-02-01 2008-02-01 Breast implant with internal flow dampening Abandoned US20090198329A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12024835 US20090198329A1 (en) 2008-02-01 2008-02-01 Breast implant with internal flow dampening

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12024835 US20090198329A1 (en) 2008-02-01 2008-02-01 Breast implant with internal flow dampening
PCT/US2009/032259 WO2009097347A1 (en) 2008-02-01 2009-01-28 Breast implant with internal flow dampening
EP20090706179 EP2247261A1 (en) 2008-02-01 2009-01-28 Breast implant with internal flow dampening
US14042457 US9333070B2 (en) 2008-02-01 2013-09-30 Breast implant with internal flow dampening
US14179235 US20140163696A1 (en) 2008-02-01 2014-02-12 Porous implant with effective extensibility and methods of forming an implant

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14042457 Continuation US9333070B2 (en) 2008-02-01 2013-09-30 Breast implant with internal flow dampening

Publications (1)

Publication Number Publication Date
US20090198329A1 true true US20090198329A1 (en) 2009-08-06

Family

ID=40932446

Family Applications (2)

Application Number Title Priority Date Filing Date
US12024835 Abandoned US20090198329A1 (en) 2008-02-01 2008-02-01 Breast implant with internal flow dampening
US14042457 Active 2028-06-27 US9333070B2 (en) 2008-02-01 2013-09-30 Breast implant with internal flow dampening

Family Applications After (1)

Application Number Title Priority Date Filing Date
US14042457 Active 2028-06-27 US9333070B2 (en) 2008-02-01 2013-09-30 Breast implant with internal flow dampening

Country Status (1)

Country Link
US (2) US20090198329A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010136840A2 (en) * 2009-05-27 2010-12-02 Carrasco Ernesto Miguel Andrade Breast prosthesis having a position indicator and a textured base and including a peripheral reinforcing ring
US20150245902A1 (en) * 2011-10-19 2015-09-03 Hilton Becker Hybrid breast implant, method for making and using same

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170209618A1 (en) * 2016-01-08 2017-07-27 Mark A. Anton COMPOSITE ePTFE AND SILICONE SOFT TISSUE IMPLANTS TO MINIMIZE CAPSULAR CONTRACTURE, WEIGHT, INFECTION AND PALPABILITY

Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3293663A (en) * 1963-08-12 1966-12-27 Dow Corning Surgically implantable human breast prosthesis
US3366975A (en) * 1965-06-04 1968-02-06 William J. Pangman Compound prosthesis
US4433440A (en) * 1979-02-26 1984-02-28 Cohen I Kelman Prosthesis formed by inner and outer inflatable containers
US5496367A (en) * 1993-01-13 1996-03-05 Fisher; Jack Breast implant with baffles
US5658330A (en) * 1993-12-23 1997-08-19 Mcghan Medical Corp. Molded silicone foam implant and method for making
US6251137B1 (en) * 1994-03-23 2001-06-26 Mcghan Medical Corporation Synthetic triglyceride filler material for surgically implanted prostheses
US6520989B1 (en) * 2000-01-18 2003-02-18 Board Of Trustees Of The University Of Arkansas Extreme volume flexible integrity prosthesis
US6755861B2 (en) * 2001-10-16 2004-06-29 Granit Medical Innovation, Inc. Device for providing a portion of an organism with a desired shape
US20040176841A1 (en) * 2001-08-24 2004-09-09 Ferguson Terrell W. Medical prosthesis
US20050187624A1 (en) * 1997-10-10 2005-08-25 Corbitt John D.Jr. Tissue marking implant
US20060161253A1 (en) * 2004-09-16 2006-07-20 Michael Lesh Tissue augmentation device
US20060282164A1 (en) * 2005-06-08 2006-12-14 Joann Seastrom Implant shell and filler apparatus
US20090125107A1 (en) * 2007-11-14 2009-05-14 Maxwell G Patrick Interfaced Medical Implant Assembly
US20090149953A1 (en) * 2007-12-10 2009-06-11 Schuessler David J Form stable breast implant sizer and method of use
US20100249947A1 (en) * 2009-03-27 2010-09-30 Evera Medical, Inc. Porous implant with effective extensibility and methods of forming an implant
US20100249946A1 (en) * 2009-03-27 2010-09-30 Evera Medical, Inc. Transcutaneously adjustable fluid-filled implants

Family Cites Families (188)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2512568A (en) 1946-08-13 1950-06-20 Jacob A Saffir Hypodermic injection device
CA962021A (en) 1970-05-21 1975-02-04 Robert W. Gore Porous products and process therefor
US3919724A (en) 1974-06-07 1975-11-18 Medical Eng Corp Implantable prosthesis having a self-sealing valve
US3934274A (en) 1974-10-29 1976-01-27 Hartley Jr John H Deflatable mammary augmentation prosthesis
US3949073A (en) 1974-11-18 1976-04-06 The Board Of Trustees Of Leland Stanford Junior University Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution
US4051840A (en) 1976-01-05 1977-10-04 Sinai Hospital Of Detroit Dynamic aortic patch
GB2041377B (en) 1979-01-22 1983-09-28 Woodroof Lab Inc Bio compatible and blood compatible materials and methods
US4327734A (en) 1979-01-24 1982-05-04 White Jr Robert I Therapeutic method of use for miniature detachable balloon catheter
FR2453145B1 (en) 1979-04-06 1981-03-27 Ugine Kuhlmann
US4395806A (en) 1980-05-08 1983-08-02 Sorenson Research Co., Inc. Method of manufacturing a detachable balloon catheter assembly
US4545367A (en) 1982-07-16 1985-10-08 Cordis Corporation Detachable balloon catheter and method of use
US4643733A (en) 1983-04-04 1987-02-17 Hilton Becker Permanent reconstruction implant and method of performing human tissue expansion
US4531244A (en) 1983-07-14 1985-07-30 Hamas Robert S Mammary prosthesis with multiple flow spaces
US4517979A (en) 1983-07-14 1985-05-21 Cordis Corporation Detachable balloon catheter
US4631188A (en) 1983-08-31 1986-12-23 S.K.Y. Polymers, Ltd. (Kingston Technologies) Injectable physiologically-acceptable polymeric composition
US4543088A (en) 1983-11-07 1985-09-24 American Hospital Supply Corporation Self-sealing subcutaneous injection site
US4820303A (en) 1984-08-30 1989-04-11 Daniel Brauman Implantable prosthetic devices
US4648880A (en) 1984-08-30 1987-03-10 Daniel Brauman Implantable prosthetic devices
US4963150B1 (en) 1984-08-30 1994-10-04 Daniel Brauman Implantable prosthetic device
US4944749A (en) 1985-01-23 1990-07-31 Hilton Becker Implant and inflating construction
US4863470A (en) 1985-03-19 1989-09-05 Medical Engineering Corporation Identification marker for a breast prosthesis
US4592755A (en) 1985-06-11 1986-06-03 Ethyl Corporation Mammary implant
US4840615A (en) 1985-09-30 1989-06-20 Mcghan Medical Corporation Self-sealing injection reservoir
US4738657A (en) 1985-09-30 1988-04-19 Mcghan Medical Corporation Self-sealing injection reservoir
US4664655A (en) 1986-03-20 1987-05-12 Norman Orentreich High viscosity fluid delivery system
US5007929B1 (en) 1986-11-04 1994-08-30 Medical Products Dev Open-cell silicone-elastomer medical implant
CA1322441C (en) 1986-11-04 1993-09-28 Joel Quaid Open-cell, silicone-elastomer medical implant and method for making
US4828827A (en) 1986-12-12 1989-05-09 Ethicon, Inc. Process for augmenting soft tissue with cross-linked polyvinyl pyrrolidone
US4994028A (en) 1987-03-18 1991-02-19 Endocon, Inc. Injector for inplanting multiple pellet medicaments
US4772287A (en) 1987-08-20 1988-09-20 Cedar Surgical, Inc. Prosthetic disc and method of implanting
US4955907A (en) 1987-12-22 1990-09-11 Ledergerber Walter J Implantable prosthetic device
US6228116B1 (en) 1987-12-22 2001-05-08 Walter J. Ledergerber Tissue expander
US5282856A (en) 1987-12-22 1994-02-01 Ledergerber Walter J Implantable prosthetic device
US4969901A (en) 1988-06-28 1990-11-13 Binder William J Plastic surgery implant
DE68904273T2 (en) 1988-08-08 1993-07-22 Marianna Calogero Ausdehnungsfaehige prosthesis for the improvement of muscular dystrophy.
US4917646A (en) 1988-08-17 1990-04-17 Kieves G Self-sealing valve, a self-sealing, non-latex balloon, and a method for producing such a balloon
USRE37950E1 (en) 1990-04-24 2002-12-31 Atrix Laboratories Biogradable in-situ forming implants and methods of producing the same
FR2645029B1 (en) 1989-03-28 1997-09-12 Cordis Sa Membrane tank implantable under the skin of a patient
US5074878A (en) 1989-04-24 1991-12-24 Medical Engineering Corporation Tissue expander and method
US4908029A (en) 1989-04-25 1990-03-13 Medical Engineering Corporation Flexible needle stop
US5019101A (en) 1989-05-31 1991-05-28 Purkait Bobby K Self-sealing valve for implantable device
US5116387A (en) 1989-06-09 1992-05-26 American Medical Systems, Inc. Preparation of injectable polymeric bodies
FR2649324B1 (en) 1989-07-06 1991-10-31 Dow Corning Sa flexible article for surgery, the assembly comprising and a method of using
US5487897A (en) 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
US4966478A (en) 1989-08-14 1990-10-30 Kuo Chun Liang Mechanically controlled-writing apparatus with presharpened pencil lead elements
US5514153A (en) 1990-03-02 1996-05-07 General Surgical Innovations, Inc. Method of dissecting tissue layers
JP2514087Y2 (en) 1990-05-25 1996-10-16 幸三 牧田 Breakaway both ends check valve with Bal - down
US5098779A (en) 1990-06-25 1992-03-24 W. L. Gore & Associates, Inc. Carvable implant material
US5188558A (en) 1991-01-02 1993-02-23 Barton Leslie W Self-sealing refillable plastic balloon valve
US5141508A (en) 1991-01-14 1992-08-25 Medical Engineering Corporation Tissue expander
US5454788A (en) 1991-04-24 1995-10-03 Baxter International Inc. Exchangeable integrated-wire balloon catheter
US5911757A (en) 1991-05-16 1999-06-15 Seare, Jr.; William J. Methods and apparatus for transcutaneous access
US5356429A (en) 1991-05-16 1994-10-18 Seare William J Jr Body pocket maintenance prosthesis
US5123905A (en) 1991-06-07 1992-06-23 Kelman Charles D Intraocular lens injector
CA2110499C (en) 1991-06-14 1998-06-23 Stanislaw L. Zukowski Surface modified porous expanded polytetrafluoroethylene and process for making
US5795325A (en) 1991-07-16 1998-08-18 Heartport, Inc. Methods and apparatus for anchoring an occluding member
NL9101489A (en) 1991-09-03 1993-04-01 Texas Instruments Holland Injector for hypodermically implanting an object into a living being.
US5213574A (en) 1991-09-06 1993-05-25 Device Labs, Inc. Composite implantable biocompatible vascular access port device
US5376117A (en) 1991-10-25 1994-12-27 Corvita Corporation Breast prostheses
US5645081A (en) 1991-11-14 1997-07-08 Wake Forest University Method of treating tissue damage and apparatus for same
US5324259A (en) 1991-12-18 1994-06-28 Advanced Cardiovascular Systems, Inc. Intravascular catheter with means to seal guidewire port
US5549672A (en) 1991-12-26 1996-08-27 Mentor Corporation Method and apparatus for filling mammary prostheses and tissue expanders
US6537574B1 (en) 1992-02-11 2003-03-25 Bioform, Inc. Soft tissue augmentation material
US5496370A (en) 1992-03-13 1996-03-05 Robert S. Hamas Gel-like prosthetic device
WO1993021850A1 (en) 1992-05-04 1993-11-11 Rosenberg Paul H Tissue expander apparatus
US5766246A (en) 1992-05-20 1998-06-16 C. R. Bard, Inc. Implantable prosthesis and method and apparatus for loading and delivering an implantable prothesis
US6312442B1 (en) 1992-06-02 2001-11-06 General Surgical Innovations, Inc. Method for developing an anatomic space for laparoscopic hernia repair
US5690666A (en) 1992-11-18 1997-11-25 Target Therapeutics, Inc. Ultrasoft embolism coils and process for using them
EP0784487A1 (en) 1993-03-19 1997-07-23 Medinvent A composition and a method for tissue augmentation
US6241747B1 (en) 1993-05-03 2001-06-05 Quill Medical, Inc. Barbed Bodily tissue connector
US5480430A (en) 1993-06-04 1996-01-02 Mcghan Medical Corporation Shape-retaining shell for a fluid filled prosthesis
ES2186688T3 (en) 1993-07-12 2003-05-16 Univ California Kit for soft tissue augmentation.
US5964803A (en) 1993-07-27 1999-10-12 Pmt Corporation Enhanced surface implant and method of manufacture
US5456716A (en) 1993-08-25 1995-10-10 Pmt Corporation Elastomeric valve assembly
US5425747A (en) 1993-10-12 1995-06-20 Brotz; Gregory R. Suture
US5584859A (en) 1993-10-12 1996-12-17 Brotz; Gregory R. Suture assembly
US5545220A (en) 1993-11-04 1996-08-13 Lipomatrix Incorporated Implantable prosthesis with open cell textured surface and method for forming same
US5643783A (en) 1993-12-01 1997-07-01 President And Fellows Of Harvard College Collagen and uses therefor
US5387192A (en) 1994-01-24 1995-02-07 Sims Deltec, Inc. Hybrid portal and method
EP0744968A1 (en) 1994-02-17 1996-12-04 W.L. GORE & ASSOCIATES, INC. A carvable ptfe implant material
US6060639A (en) 1994-03-04 2000-05-09 Mentor Corporation Testicular prosthesis and method of manufacturing and filling
CA2193651C (en) 1994-03-04 2005-07-26 Timothy B. Petrick Improved self-sealing injection sites and plugs, implantable prosthesis and other devices utilizing same and method of manufacture
US6582461B1 (en) 1994-05-19 2003-06-24 Scimed Life Systems, Inc. Tissue supporting devices
US5571189A (en) 1994-05-20 1996-11-05 Kuslich; Stephen D. Expandable fabric implant for stabilizing the spinal motion segment
US5630843A (en) 1994-06-30 1997-05-20 Rosenberg; Paul H. Double chamber tissue expander
US5461781A (en) 1994-07-01 1995-10-31 Warner-Lambert Company Dynamic shaving system with integral push clean bar and spring member
JP3359036B2 (en) 1994-08-10 2002-12-24 マロエ ヴネドゥレンチェスコエ プレドゥプリヤティエ ”インテルファルル” Hydrogel biocompatible
DE59509755D1 (en) 1994-08-17 2001-11-29 Boston Scient Corp Implant and application device
EP1009317A4 (en) 1997-08-28 2001-01-24 Boston Scient Corp System for implanting a cross-linked polysaccharide fiber and methods of forming and inserting the fiber
US5599852A (en) 1994-10-18 1997-02-04 Ethicon, Inc. Injectable microdispersions for soft tissue repair and augmentation
NL9401805A (en) 1994-10-31 1996-06-03 Gijsbertus Gerardus Petrus Van Device for firing by means of compressed air from a rigid support.
WO1996032153A1 (en) 1995-04-14 1996-10-17 Interventional Therapeutics Corporation Dual valve detachable occlusion balloon and over-the-wire delivery apparatus and method for use therewith
US5645558A (en) 1995-04-20 1997-07-08 Medical University Of South Carolina Anatomically shaped vasoocclusive device and method of making the same
US5545217A (en) 1995-04-20 1996-08-13 C.M. Offray & Son, Inc. Breast implant
US6470216B1 (en) 1995-05-05 2002-10-22 Thermage, Inc. Method for smoothing contour irregularities of skin surface
US5624461A (en) 1995-06-06 1997-04-29 Target Therapeutics, Inc. Three dimensional in-filling vaso-occlusive coils
US5630844A (en) 1995-06-07 1997-05-20 Novamed Medical Products Manufacturing, Inc. Biocompatible hydrophobic laminate with thermoplastic elastomer layer
US5989216A (en) 1995-06-29 1999-11-23 Sims Deltec, Inc. Access portal and method
US5662708A (en) 1995-08-08 1997-09-02 Novamed Medical Products Manufacturing, Inc. Rheologically modified and osmotically balanced fill material for implant
US5582585A (en) 1995-09-25 1996-12-10 Nash-Morgan; Leonora E. Disposable elastic neck and facial wrinkle gathering device
US5716413A (en) 1995-10-11 1998-02-10 Osteobiologics, Inc. Moldable, hand-shapable biodegradable implant material
US6283951B1 (en) 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
US6090063A (en) 1995-12-01 2000-07-18 C. R. Bard, Inc. Device, system and method for implantation of filaments and particles in the body
US5645597A (en) 1995-12-29 1997-07-08 Krapiva; Pavel I. Disc replacement method and apparatus
US5861032A (en) 1996-01-31 1999-01-19 Surface Genesis, Inc. Medical device having a biocompatible coating and oxidation method of coupling therefor
US5871537A (en) 1996-02-13 1999-02-16 Scimed Life Systems, Inc. Endovascular apparatus
US6171298B1 (en) 1996-05-03 2001-01-09 Situs Corporation Intravesical infuser
US6530896B1 (en) 1996-05-13 2003-03-11 James B. Elliott Apparatus and method for introducing an implant
US5964261A (en) 1996-05-29 1999-10-12 Baxter International Inc. Implantation assembly
US5702677A (en) 1996-07-10 1997-12-30 Osteotech, Inc. Spherical hydroxyapatite particles and process for the production thereof
US5824081A (en) 1996-09-13 1998-10-20 Lipomatrix Incorporated Hydraulic foam tissue implant
US5855588A (en) 1996-10-03 1999-01-05 General Surgical Innovations, Inc. Combination dissector and expander
WO1998019625A3 (en) 1996-11-08 1998-07-02 Russell A Houser Percutaneous bypass graft and securing system
WO1998020939A3 (en) 1996-11-15 1998-09-03 Advanced Bio Surfaces Inc Biomaterial system for in situ tissue repair
DE69715403T2 (en) 1996-12-19 2003-04-17 Neto Mateus Sommer Injectable compositions and methods for their preparation.
US6296624B1 (en) 1997-02-04 2001-10-02 Allen Gerber Body access system
US5935164A (en) 1997-02-25 1999-08-10 Pmt Corporaton Laminated prosthesis and method of manufacture
US20020019670A1 (en) 1997-02-28 2002-02-14 Jerald M. Crawley Implantable tissue augmentation device
US6146418A (en) 1997-02-28 2000-11-14 Berman; Mark Body implant and method of implanting
US5931855A (en) 1997-05-21 1999-08-03 Frank Hoffman Surgical methods using one-way suture
RU2158552C2 (en) 1997-06-10 2000-11-10 Нижегородский государственный научно-исследовательский институт травматологии и ортопедии Method of surgical treatment of postburn defects of head soft tissues
FR2764514B1 (en) 1997-06-13 1999-09-03 Biopharmex Holding Sa injectable implant subcutaneous or intradermal has bioresorbability controlled for restorative or plastic surgery and aesthetic dermatology
GB9714580D0 (en) 1997-07-10 1997-09-17 Wardlaw Douglas Prosthetic intervertebral disc nucleus
GB9715241D0 (en) 1997-07-18 1997-09-24 Jeffree Martin A Device for treating aneurysms
US5957939A (en) 1997-07-31 1999-09-28 Imagyn Medical Technologies, Inc. Medical device for deploying surgical fabrics
US5961552A (en) 1997-08-02 1999-10-05 Pmt Corporation Internally configured prosthesis
US6322576B1 (en) 1997-08-29 2001-11-27 Target Therapeutics, Inc. Stable coil designs
WO1999013781A1 (en) 1997-09-16 1999-03-25 Luescher Patrik Device for implanting filamentous materials
DE69831342T2 (en) 1997-10-02 2006-06-29 Boston Scientific Ltd., St. Michael Device for introducing fiber materials into the body
WO1999017816A1 (en) 1997-10-03 1999-04-15 Gore Enterprise Holdings, Inc. An expanded ptfe covered space-filling implant
JP2001519203A (en) 1997-10-10 2001-10-23 ジョン・ディ・コービット・ジュニア Breast implant
US6039712A (en) 1997-11-04 2000-03-21 Terence M. Fogarty Implantable injection port
US5944738A (en) 1998-02-06 1999-08-31 Aga Medical Corporation Percutaneous catheter directed constricting occlusion device
US6660301B1 (en) 1998-03-06 2003-12-09 Biosphere Medical, Inc. Injectable microspheres for dermal augmentation and tissue bulking
US6264700B1 (en) 1998-08-27 2001-07-24 Endonetics, Inc. Prosthetic gastroesophageal valve
US6478656B1 (en) 1998-12-01 2002-11-12 Brava, Llc Method and apparatus for expanding soft tissue with shape memory alloys
WO2000033771A9 (en) 1998-12-11 2001-05-10 Gerald W Johnson Implants filled with solid or semi-solid material
US6231613B1 (en) 1998-12-15 2001-05-15 Enteric Medical Technologies, Inc. Methods for soft tissue augmentation in mammals
US6740082B2 (en) 1998-12-29 2004-05-25 John H. Shadduck Surgical instruments for treating gastro-esophageal reflux
US6312405B1 (en) 1999-02-02 2001-11-06 American Medical Systems, Inc. Self-sealing detachable balloon
US20030225453A1 (en) 1999-03-03 2003-12-04 Trivascular, Inc. Inflatable intraluminal graft
US6261316B1 (en) 1999-03-11 2001-07-17 Endologix, Inc. Single puncture bifurcation graft deployment system
US6098629A (en) 1999-04-07 2000-08-08 Endonetics, Inc. Submucosal esophageal bulking device
US6338345B1 (en) 1999-04-07 2002-01-15 Endonetics, Inc. Submucosal prosthesis delivery device
US6315796B1 (en) 1999-05-13 2001-11-13 Board Of Trustees Of The University Of Arkansas Flexible seamless memory tissue expanding implant
US6162251A (en) 1999-05-25 2000-12-19 Novamed Medical Products Manufacturing, Inc. Saline implant having single valve with primary and secondary closures
US6379329B1 (en) 1999-06-02 2002-04-30 Cordis Neurovascular, Inc. Detachable balloon embolization device and method
US6277150B1 (en) 1999-06-11 2001-08-21 Gore Enterprise Holdings, Inc. Facial implant having one porous surface
US6471689B1 (en) 1999-08-16 2002-10-29 Thomas Jefferson University Implantable drug delivery catheter system with capillary interface
US6390096B1 (en) 1999-09-17 2002-05-21 Pi Medical, Inc. Needle with pre-loaded implant for snoring treatment
US6478809B1 (en) 2000-02-04 2002-11-12 Gregory R. Brotz Suture and method of use
US6270517B1 (en) 2000-02-04 2001-08-07 Gregory R. Brotz Suture assembly and method
FR2805168B1 (en) 2000-02-18 2003-01-10 Cie Euro Etude Rech Paroscopie An implantable injection of medical substances device
US6485503B2 (en) 2000-05-19 2002-11-26 Coapt Systems, Inc. Multi-point tissue tension distribution device, a brow and face lift variation, and a method of tissue approximation using the device
US7172615B2 (en) 2000-05-19 2007-02-06 Coapt Systems, Inc. Remotely anchored tissue fixation device
US6537242B1 (en) 2000-06-06 2003-03-25 Becton, Dickinson And Company Method and apparatus for enhancing penetration of a member for the intradermal sampling or administration of a substance
US6899713B2 (en) 2000-06-23 2005-05-31 Vertelink Corporation Formable orthopedic fixation system
US20020025340A1 (en) 2000-08-30 2002-02-28 Dyer Wallace K. Methods and compositions for tissue augmentation
US6296607B1 (en) 2000-10-20 2001-10-02 Praxis, Llc. In situ bulking device
US6648853B1 (en) 2000-10-31 2003-11-18 Agilent Technologies Inc. Septum
US6673105B1 (en) 2001-04-02 2004-01-06 Advanced Cardiovascular Systems, Inc. Metal prosthesis coated with expandable ePTFE
US6599310B2 (en) 2001-06-29 2003-07-29 Quill Medical, Inc. Suture method
US6684107B1 (en) 2001-08-01 2004-01-27 Voyager Medical Corporation Wrinkle-reducing system
US6554809B2 (en) 2001-08-02 2003-04-29 Teodulo Aves Epidural catheter needle
US6663596B2 (en) 2001-08-13 2003-12-16 Scimed Life Systems, Inc. Delivering material to a patient
US6551342B1 (en) 2001-08-24 2003-04-22 Endovascular Technologies, Inc. Embolic filter
EP1511522B1 (en) 2002-06-12 2011-08-10 Boston Scientific Limited Bulking agents
US8162966B2 (en) 2002-10-25 2012-04-24 Hydrocision, Inc. Surgical devices incorporating liquid jet assisted tissue manipulation and methods for their use
US7008455B2 (en) 2003-03-07 2006-03-07 Surgisil, L.L.P. Lip implant, instrumentation and method for insertion
US7081135B2 (en) 2003-06-09 2006-07-25 Lane Fielding Smith Mastopexy stabilization apparatus and method
US6743208B1 (en) 2003-06-19 2004-06-01 Medtronic Vascular, Inc Occlusion balloon catheter with distal valve
US6802861B1 (en) 2003-08-26 2004-10-12 Rsh-Gs Trust Structured breast implant
US20050131325A1 (en) 2003-12-16 2005-06-16 How-Lun Chen Flexible injection port
WO2006034077A1 (en) 2004-09-16 2006-03-30 Juva Medical, Inc. Tissue augmentation device
US7244270B2 (en) 2004-09-16 2007-07-17 Evera Medical Systems and devices for soft tissue augmentation
US20060058890A1 (en) 2004-09-16 2006-03-16 Lesh Michael D Methods for soft tissue augmentation
US20060058892A1 (en) 2004-09-16 2006-03-16 Lesh Michael D Valved tissue augmentation implant
US20060058891A1 (en) 2004-09-16 2006-03-16 Lesh Michael D Transformable tissue bulking device
US7559952B2 (en) 2004-12-17 2009-07-14 Innovia, Llc Elastomeric polymer filament cosmetic implant
US7758649B2 (en) * 2006-08-04 2010-07-20 Integrity Intellect Inc. Reversibly deformable implant
US20080221679A1 (en) 2007-03-06 2008-09-11 Ideal Implant Incorporated Collapse-Resistant Breast Implant With Stiffened Walls
US20080221678A1 (en) 2007-03-06 2008-09-11 Ideal Implant Incorporated Collapse-Resistant Breast Implant With Partial Internal Shells
US20090198328A1 (en) 2008-02-01 2009-08-06 Kesten Randy J Breast implant with adjustable compression response
US20090198331A1 (en) 2008-02-01 2009-08-06 Kesten Randy J Implantable prosthesis with open cell flow regulation
US20090198330A1 (en) 2008-02-01 2009-08-06 Kesten Randy J Compressible cosmetic prosthesis with improved shape retention
US20100087922A1 (en) 2008-10-07 2010-04-08 Ideal Implant Incorporated Kit and Method for Comparison of Breast Implants
US9084668B2 (en) 2008-12-01 2015-07-21 Ideal Implant Incorporated Packaging for sterile implant
US8556968B2 (en) 2011-11-09 2013-10-15 Ideal Implant Incorporated Breast implant with low coefficient of friction between internal shells in an aqueous fluid environment

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3293663A (en) * 1963-08-12 1966-12-27 Dow Corning Surgically implantable human breast prosthesis
US3366975A (en) * 1965-06-04 1968-02-06 William J. Pangman Compound prosthesis
US4433440A (en) * 1979-02-26 1984-02-28 Cohen I Kelman Prosthesis formed by inner and outer inflatable containers
US5496367A (en) * 1993-01-13 1996-03-05 Fisher; Jack Breast implant with baffles
US5658330A (en) * 1993-12-23 1997-08-19 Mcghan Medical Corp. Molded silicone foam implant and method for making
US6251137B1 (en) * 1994-03-23 2001-06-26 Mcghan Medical Corporation Synthetic triglyceride filler material for surgically implanted prostheses
US20050187624A1 (en) * 1997-10-10 2005-08-25 Corbitt John D.Jr. Tissue marking implant
US6520989B1 (en) * 2000-01-18 2003-02-18 Board Of Trustees Of The University Of Arkansas Extreme volume flexible integrity prosthesis
US20040176841A1 (en) * 2001-08-24 2004-09-09 Ferguson Terrell W. Medical prosthesis
US6755861B2 (en) * 2001-10-16 2004-06-29 Granit Medical Innovation, Inc. Device for providing a portion of an organism with a desired shape
US20060161253A1 (en) * 2004-09-16 2006-07-20 Michael Lesh Tissue augmentation device
US7641688B2 (en) * 2004-09-16 2010-01-05 Evera Medical, Inc. Tissue augmentation device
US20060282164A1 (en) * 2005-06-08 2006-12-14 Joann Seastrom Implant shell and filler apparatus
US20090125107A1 (en) * 2007-11-14 2009-05-14 Maxwell G Patrick Interfaced Medical Implant Assembly
US20090149953A1 (en) * 2007-12-10 2009-06-11 Schuessler David J Form stable breast implant sizer and method of use
US20100249947A1 (en) * 2009-03-27 2010-09-30 Evera Medical, Inc. Porous implant with effective extensibility and methods of forming an implant
US20100249946A1 (en) * 2009-03-27 2010-09-30 Evera Medical, Inc. Transcutaneously adjustable fluid-filled implants

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Wikipedia. "Viscosity". Downloaded from on 03/23/2013. *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010136840A2 (en) * 2009-05-27 2010-12-02 Carrasco Ernesto Miguel Andrade Breast prosthesis having a position indicator and a textured base and including a peripheral reinforcing ring
WO2010136840A3 (en) * 2009-05-27 2011-08-04 Carrasco Ernesto Miguel Andrade Breast prosthesis having a position indicator and a textured base and including a peripheral reinforcing ring
US20150245902A1 (en) * 2011-10-19 2015-09-03 Hilton Becker Hybrid breast implant, method for making and using same

Also Published As

Publication number Publication date Type
US9333070B2 (en) 2016-05-10 grant
US20140135923A1 (en) 2014-05-15 application

Similar Documents

Publication Publication Date Title
US3366975A (en) Compound prosthesis
US4950292A (en) Tissue expanders
US4902293A (en) Intraocular lens with inflatable haptic
US4958630A (en) Method and apparatus for treating impotence
US4637377A (en) Pillow or support member for surgical use
US6083262A (en) Supple implantable prosthesis used in surgery for increasing the volume of or reconstructing soft tissue, notably a breast prosthesis, and its method of manufacture
US7758493B2 (en) Gastric constriction device
US4386601A (en) Artificial sphincter
US4969899A (en) Inflatable implant
US4558693A (en) Penile implant
US5108456A (en) Prosthetic appliance
US5752525A (en) Urethral plug assembly having adhesive for enhanced sealing capabilities and method of using said plug assembly
US5480430A (en) Shape-retaining shell for a fluid filled prosthesis
US5133776A (en) Prosthetic volume compensation device
US5344388A (en) Textured surface prosthetic device
US4829990A (en) Implantable hydraulic penile erector
US4790848A (en) Breast prosthesis with multiple lumens
US20040143319A1 (en) Vascular pressure differential device and method of use
US6149691A (en) Self-inflating socket having encased gel
US5984943A (en) Combination dissector and expander
US5935164A (en) Laminated prosthesis and method of manufacture
US4539980A (en) Male organ conditioner
US5447535A (en) Mammary prosthesis
US4587954A (en) Elastomeric prosthetic sphincter
US5662583A (en) Mechanical soft tissue enlarger

Legal Events

Date Code Title Description
AS Assignment

Owner name: EVERA MEDICAL, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KESTEN, RANDY J.;LESH, MICHAEL D.;REEL/FRAME:020835/0136

Effective date: 20080417

AS Assignment

Owner name: VENTURE LENDING & LEASING IV, INC., CALIFORNIA

Free format text: SECURITY AGREEMENT;ASSIGNOR:EVERA MEDICAL, INC.;REEL/FRAME:022694/0334

Effective date: 20090504

Owner name: VENTURE LENDING & LEASING V, INC., CALIFORNIA

Free format text: SECURITY AGREEMENT;ASSIGNOR:EVERA MEDICAL, INC.;REEL/FRAME:022694/0334

Effective date: 20090504

AS Assignment

Owner name: KNOBBE, MARTENS, OLSON & BEAR, LLP,CALIFORNIA

Free format text: SECURITY INTEREST;ASSIGNOR:EVERA MEDICAL, INC.;REEL/FRAME:024390/0108

Effective date: 20100311

Owner name: KNOBBE, MARTENS, OLSON & BEAR, LLP, CALIFORNIA

Free format text: SECURITY INTEREST;ASSIGNOR:EVERA MEDICAL, INC.;REEL/FRAME:024390/0108

Effective date: 20100311